vs
Concentra Group Holdings Parent, Inc.（CON）与FMC CORP（FMC）财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是Concentra Group Holdings Parent, Inc.的1.3倍（$759.0M vs $569.6M），Concentra Group Holdings Parent, Inc.净利率更高（9.2% vs -37.0%，领先46.2%），Concentra Group Holdings Parent, Inc.同比增速更快（13.7% vs -4.0%），Concentra Group Holdings Parent, Inc.自由现金流更多（$9.9M vs $-628.1M）
Concentra是美国的职业医疗服务商，1979年成立于得克萨斯州阿马里洛，总部位于得克萨斯州艾迪生。业务覆盖美国47个州，运营627家职业医疗中心和410个雇主驻地现场诊所，美国每7起职业伤害案例中就有1起由该机构提供诊疗服务。
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业，1883年创立之初以生产杀虫剂为主，后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车，目前在全球拥有7000名员工，业务布局广泛。
CON vs FMC — 直观对比
营收规模更大
FMC
是对方的1.3倍
$569.6M
营收增速更快
CON
高出17.8%
-4.0%
净利率更高
CON
高出46.2%
-37.0%
自由现金流更多
CON
多$638.0M
$-628.1M
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $569.6M | $759.0M |
| 净利润 | $52.3M | $-281.2M |
| 毛利率 | — | — |
| 营业利润率 | 16.8% | -10.6% |
| 净利率 | 9.2% | -37.0% |
| 营收同比 | 13.7% | -4.0% |
| 净利润同比 | 28.7% | — |
| 每股收益（稀释后） | $0.39 | $-2.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CONFMC
| Q1 26 | $569.6M | $759.0M | ||
| Q4 25 | $539.1M | $1.1B | ||
| Q3 25 | $572.8M | $542.2M | ||
| Q2 25 | $550.8M | $1.1B | ||
| Q1 25 | $500.8M | $791.4M | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | $489.6M | $1.1B | ||
| Q2 24 | $477.9M | $1.0B |
净利润CONFMC
| Q1 26 | $52.3M | $-281.2M | ||
| Q4 25 | $34.7M | $-1.7B | ||
| Q3 25 | $48.3M | $-569.3M | ||
| Q2 25 | $44.6M | $66.7M | ||
| Q1 25 | $38.9M | $-15.5M | ||
| Q4 24 | — | $-16.3M | ||
| Q3 24 | $44.3M | $65.0M | ||
| Q2 24 | $51.7M | $295.1M |
毛利率CONFMC
| Q1 26 | — | — | ||
| Q4 25 | — | 39.8% | ||
| Q3 25 | — | 23.8% | ||
| Q2 25 | — | 38.7% | ||
| Q1 25 | — | 40.0% | ||
| Q4 24 | — | 42.9% | ||
| Q3 24 | — | 36.3% | ||
| Q2 24 | — | 38.3% |
营业利润率CONFMC
| Q1 26 | 16.8% | -10.6% | ||
| Q4 25 | 12.9% | -130.8% | ||
| Q3 25 | 16.5% | -73.1% | ||
| Q2 25 | 16.3% | 12.0% | ||
| Q1 25 | 16.0% | 7.4% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | 17.6% | 12.7% | ||
| Q2 24 | 17.6% | 6.0% |
净利率CONFMC
| Q1 26 | 9.2% | -37.0% | ||
| Q4 25 | 6.4% | -158.8% | ||
| Q3 25 | 8.4% | -105.0% | ||
| Q2 25 | 8.1% | 6.3% | ||
| Q1 25 | 7.8% | -2.0% | ||
| Q4 24 | — | -1.3% | ||
| Q3 24 | 9.1% | 6.1% | ||
| Q2 24 | 10.8% | 28.4% |
每股收益（稀释后）CONFMC
| Q1 26 | $0.39 | $-2.25 | ||
| Q4 25 | $0.27 | $-13.77 | ||
| Q3 25 | $0.38 | $-4.52 | ||
| Q2 25 | $0.35 | $0.53 | ||
| Q1 25 | $0.30 | $-0.12 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $0.37 | $0.52 | ||
| Q2 24 | $0.50 | $2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $390.9M |
| 总债务越低越好 | $1.6B | $2.8B |
| 股东权益账面价值 | $424.7M | $1.8B |
| 总资产 | $2.9B | $9.4B |
| 负债/权益比越低杠杆越低 | 3.68× | 1.50× |
8季度趋势，按日历期对齐
现金及短期投资CONFMC
| Q1 26 | — | $390.9M | ||
| Q4 25 | $79.9M | $584.5M | ||
| Q3 25 | $49.9M | $497.7M | ||
| Q2 25 | $73.9M | $438.2M | ||
| Q1 25 | $52.1M | $315.3M | ||
| Q4 24 | — | $357.3M | ||
| Q3 24 | $136.8M | $416.7M | ||
| Q2 24 | $50.7M | $471.5M |
总债务CONFMC
| Q1 26 | $1.6B | $2.8B | ||
| Q4 25 | $1.6B | $3.4B | ||
| Q3 25 | $1.6B | $3.4B | ||
| Q2 25 | $1.7B | $3.4B | ||
| Q1 25 | $1.6B | $3.1B | ||
| Q4 24 | — | $3.1B | ||
| Q3 24 | $1.5B | $3.1B | ||
| Q2 24 | $3.0M | $3.1B |
股东权益CONFMC
| Q1 26 | $424.7M | $1.8B | ||
| Q4 25 | $393.3M | $2.1B | ||
| Q3 25 | $385.5M | $3.8B | ||
| Q2 25 | $342.6M | $4.4B | ||
| Q1 25 | $307.1M | $4.4B | ||
| Q4 24 | — | $4.5B | ||
| Q3 24 | $277.8M | $4.6B | ||
| Q2 24 | $1.2B | $4.6B |
总资产CONFMC
| Q1 26 | $2.9B | $9.4B | ||
| Q4 25 | $2.9B | $9.7B | ||
| Q3 25 | $2.8B | $12.1B | ||
| Q2 25 | $2.8B | $12.3B | ||
| Q1 25 | $2.7B | $11.8B | ||
| Q4 24 | — | $11.7B | ||
| Q3 24 | $2.5B | $12.2B | ||
| Q2 24 | $2.4B | $12.1B |
负债/权益比CONFMC
| Q1 26 | 3.68× | 1.50× | ||
| Q4 25 | 3.98× | 1.62× | ||
| Q3 25 | 4.15× | 0.89× | ||
| Q2 25 | 4.82× | 0.76× | ||
| Q1 25 | 5.27× | 0.71× | ||
| Q4 24 | — | 0.69× | ||
| Q3 24 | 5.30× | 0.68× | ||
| Q2 24 | 0.00× | 0.68× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $21.0M | — |
| 自由现金流经营现金流 - 资本支出 | $9.9M | $-628.1M |
| 自由现金流率自由现金流/营收 | 1.7% | -82.8% |
| 资本支出强度资本支出/营收 | — | 2.2% |
| 现金转化率经营现金流/净利润 | 0.40× | — |
| 过去12个月自由现金流最近4个季度 | $211.0M | $-154.0M |
8季度趋势，按日历期对齐
经营现金流CONFMC
| Q1 26 | $21.0M | — | ||
| Q4 25 | $118.7M | $657.1M | ||
| Q3 25 | $60.6M | $-184.2M | ||
| Q2 25 | $88.4M | $65.9M | ||
| Q1 25 | $11.7M | $-545.0M | ||
| Q4 24 | — | $427.9M | ||
| Q3 24 | $65.9M | $159.5M | ||
| Q2 24 | — | $292.2M |
自由现金流CONFMC
| Q1 26 | $9.9M | $-628.1M | ||
| Q4 25 | $98.5M | $631.1M | ||
| Q3 25 | $39.4M | $-207.9M | ||
| Q2 25 | $63.2M | $50.9M | ||
| Q1 25 | $-4.0M | $-576.6M | ||
| Q4 24 | — | $406.3M | ||
| Q3 24 | $50.8M | $143.8M | ||
| Q2 24 | — | $282.3M |
自由现金流率CONFMC
| Q1 26 | 1.7% | -82.8% | ||
| Q4 25 | 18.3% | 58.3% | ||
| Q3 25 | 6.9% | -38.3% | ||
| Q2 25 | 11.5% | 4.8% | ||
| Q1 25 | -0.8% | -72.9% | ||
| Q4 24 | — | 33.2% | ||
| Q3 24 | 10.4% | 13.5% | ||
| Q2 24 | — | 27.2% |
资本支出强度CONFMC
| Q1 26 | — | 2.2% | ||
| Q4 25 | 3.7% | 2.4% | ||
| Q3 25 | 3.7% | 4.4% | ||
| Q2 25 | 4.6% | 1.4% | ||
| Q1 25 | 3.1% | 4.0% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | 3.1% | 1.5% | ||
| Q2 24 | — | 1.0% |
现金转化率CONFMC
| Q1 26 | 0.40× | — | ||
| Q4 25 | 3.42× | — | ||
| Q3 25 | 1.26× | — | ||
| Q2 25 | 1.98× | 0.99× | ||
| Q1 25 | 0.30× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.49× | 2.45× | ||
| Q2 24 | — | 0.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CON
| Workers' compensation | $337.7M | 59% |
| Employer services | $172.4M | 30% |
| Onsite health clinics | $37.2M | 7% |
| Other | $14.5M | 3% |
| Consumer health | $7.8M | 1% |
FMC
| EMEA | $307.0M | 40% |
| North America | $198.0M | 26% |
| Latin America | $177.0M | 23% |
| Asia (excluding 2026 India) 1 | $81.0M | 11% |
